Amanta Healthcare files DRHP to float its IPO

Amanta Healthcare Limited - which is engaged in the development, manufacturing, and marketing of a diverse range of sterile liquid products - has filed its Draft Red Herring Prospectus (DRHP) with NSE and BSE in preparation for the IPO.

The proposed issue shall entirely be a fresh share sale of up to 1,25,00,000 equity shares with a face value of Rs 10 each. 

According to the company, its objective is to raise funds for capital expenditure requirements for civil construction work and towards the purchase of equipment, plant and machinery for setting up a new manufacturing line for SteriPortat Hariyala, Kheda, Gujarat. 

It also aims to secure funding for capital expenditure requirements towards the purchase of equipment, plant and machinery for setting up a new Small Volume Parenteral (SVP) manufacturing line at the same location and for general corporate purposes.